Shan, Xinhe http://orcid.org/0000-0003-4976-1735
Long, Qi http://orcid.org/0000-0003-0660-5230
Garfall, Alfred L. http://orcid.org/0000-0003-2791-5748
Susanibar-Adaniya, Sandra P. http://orcid.org/0000-0003-0703-2518
Article History
Received: 14 January 2023
Revised: 23 April 2023
Accepted: 4 May 2023
First Online: 22 May 2023
Competing interests
: ALG has received research funding (via the Univeristy of Pennsylvania) from Novartis, Janssen, CRISPR Therapeutics, and Tmunity Therapeutics and consulting fees from Janssen, Bristol Myers Squibb, Legend Biotech, GlaxoSmithKline, Amgen.